Bacteremia and Sepsis

  • Ellen Smith
  • Douglas M. Walsh
  • James M. Herman


Bacteremia indicates the presence of viable bacteria in the circulatory blood and is usually defined clinically as positive blood cultures.1 Sepsis is a frequently used term for “pathogenic microorganisms or their toxins in the bloodstream.”2 Septic shock is present when shock occurs in “response to serious infection.”3 The term sepsis syndrome describes “the systemic response to infection—expressed as tachycardia, fever or hypothermia, tachypnea, and evidence of inadequate organ perfusion or organ dysfunction.”2


Septic Shock Sickle Cell Disease Listeria Monocytogenes Positive Blood Culture Sickle Cell Disease Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bone RC. Sepsis, the sepsis syndrome, multi-organ failure: a plea for comparable definitions. Ann Intern Med 1991;114:332–3.PubMedCrossRefGoogle Scholar
  2. 2.
    Bone RC. Gram-negative sepsis; background, clinical features, and intervention. Chest 1991;100:802–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Parillo JE, moderator. Septic shock in humans = advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990;113:227–42.CrossRefGoogle Scholar
  4. 4.
    Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991; 115: 457–69.PubMedCrossRefGoogle Scholar
  5. 5.
    Kreger BE, Craven DE, McCabe WR. Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 1980;68:344–54.PubMedCrossRefGoogle Scholar
  6. 6.
    Baraff LJ, Oslund SA, Schriger DL. Probability of bacterial infection in febrile infants less than three months of age: a meta-analysis. Pediatr Infect Disease J 1992;11:257–65.CrossRefGoogle Scholar
  7. 7.
    Rackow EC, Astiz ME. Pathophysiology and treatment of septic shock. JAMA 1991;266:548–59.PubMedCrossRefGoogle Scholar
  8. 8.
    Mostow SC. Management of gram-negative septic shock. Hosp Pract 1990;25:121–30.Google Scholar
  9. 9.
    Murray MD, Kumar M. Sepsis and septic shock. Postgrad Med 1991;90(l):199–208.PubMedGoogle Scholar
  10. 10.
    Smally AJ. Septic shock: when patients fail to respond to conventional therapy. Postgrad Med 1991;90(3):205–12.PubMedGoogle Scholar
  11. 11.
    Mileski WJ. Sepsis: what it is and how to recognize it. Surg Clin North Am 1991;71:749–64.PubMedGoogle Scholar
  12. 12.
    Barriere SL, Ognibene FP, Summer WR, Young LS. Septic shock: beyond antibiotics. Patient Care 1991;25(25):95–109.Google Scholar
  13. 13.
    Monoclonal antibodies for gram-negative sepsis. Med Lett 1991; 33:103–4.Google Scholar
  14. 14.
    Ziegler EJ, Fisher CJ Jr, Sprung CL, et al. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 1991 ;324: 429–36.PubMedCrossRefGoogle Scholar
  15. 15.
    Schulman KA, Glick HA, Rubin H, Eisenberg JM. Cost-effectiveness of HA-1A monoclonal antibody for gram-negative sepsis. JAMA 1991;226:3466–71.CrossRefGoogle Scholar
  16. 16.
    Greenman RL, Schein RMH, Martin MA, et al. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. JAMA 1991;266: 1097–1102.PubMedCrossRefGoogle Scholar
  17. 17.
    Bone RC. A critical evaluation of new agents for the treatment of sepsis. JAMA 1991;226:1686–91.CrossRefGoogle Scholar
  18. 18.
    Weinstein MP, Murphy JR, Relier LB, Lichtenstein UA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis 1983;5:54–70.PubMedCrossRefGoogle Scholar
  19. 19.
    Richardson JP. Bacteremia in the elderly: a review. J Gen Intern Med (in press). Vol. 8;no. 2. February 1993, pg. 89–92.PubMedCrossRefGoogle Scholar
  20. 20.
    Bonadio W. Evaluation and management of serious bacterial infections in the febrile young infant. Pediatr Infect Dis J 1990;9:905–12.PubMedCrossRefGoogle Scholar
  21. 21.
    McCarthy PL, Jehel JF, Stashwick CA, et al. History and observation variables in assessing febrile children. Pediatrics 1980;65: 1090–5.PubMedGoogle Scholar
  22. 22.
    McLellin D, Giebrick GS. Perspectives in occult bacteremia in children. J Pediatr 1986;109:1–7.CrossRefGoogle Scholar
  23. 23.
    Lieu TA, Schwartz S, Jaffe DM. Strategies for diagnosis and treatment of children at risk for occult bacteremia: clinical effectiveness and cost effectiveness. J Pediatr 1991;118:21–29.PubMedCrossRefGoogle Scholar
  24. 24.
    Downs SM, McNutt RA, Margolis PA. Management of infants at risk for occult bacteremia: a decision analysis. J Pediatr 1991; 118:11–20.PubMedCrossRefGoogle Scholar
  25. 25.
    McCarthy PL, Sharpe MR, Spiessel SZ. Observation scales to identify serious illness in febrile children. Pediatrics 1982;70:802–9.PubMedGoogle Scholar
  26. 26.
    Pearson HA. Sickle cell diseases: diagnosis and management in infancy and childhood. Pediatr Rev 1987;9(4): 121–30.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Ellen Smith
  • Douglas M. Walsh
  • James M. Herman

There are no affiliations available

Personalised recommendations